JPRN-UMIN000031664Recruiting未知
Evaluation of the efficacy of glecaprevir and pibrentasvir for Japanese hepatitis C patients: a prospective study in real life settings. - The efficacy of glecaprevir and pibrentasvir for Japanese hepatitis C patients.
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Toranomon Hospital
- Enrollment
- 350
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •decompensated cirrhosis
Investigators
Similar Trials
Completed
Not Applicable
Efficacy and safety of glecaprevir and pibrentasvir in chronic hepatitis C patients with hemodialysisChronic hepatitis C with hemodialysisJPRN-UMIN000029781kitasato University school of medicine50
Completed
Not Applicable
Efficacy and safety of glecaprevir/pibrentasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic Hepatitis CJPRN-UMIN000029652Saitama Medical University200
Not yet recruiting
Not Applicable
Efficacy and safety of Glecaprevir/Pibrentasvir plus Ribavirin in Patients who failed Direct-acting antivirals; DAAs with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000031615Tokai University10
Completed
Not Applicable
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hepatitis C infected patients with chronic hepatitis or liver cirrhosisJPRN-UMIN000031090Hokkaido University Hospital300
Completed
Not Applicable
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hemodialysis patients with genotype 2 hepatitis C infectioJPRN-UMIN000036099Hokkaido University Hospital40